Complementary Role of Cytology and Molecular Testing in Thyroid Nodule Management

Thank you

Thank you for attending this webinar!
Handouts for this session can be accessed via the "Resources" tab above.

Description

Presented by Trisha M Shattuck, MD, PhD
Carolinas Pathology Group
This presentation will provide an overview of the diagnostic evaluation of thyroid nodules from the perspective of a pathologist. Key topics that will be discussed include the Bethesda Cytological Classification System and the role of molecular testing in thyroid nodule management.

Learning Objectives
At the end of this session, the attendee will be able to:

Illustrate the diagnostic evaluation of an identified thyroid nodule
Describe the Bethesda Cytological Classification System for thyroid nodules
Depict the role of molecular testing in thyroid nodule management

Instruction Level: Intermediate

ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.

Contributors

Trisha M Shattuck, MD, PhD.

Dr. Trisha M. Shattuck works with Carolinas Pathology Group supporting the Atrium Healthcare System and serving as medical director of the cytology laboratory. After receiving a B.S. in biology from Yale University, she completed a combined MD/PhD program at the University of Connecticut School of Medicine where her research focused on endocrine neoplasia. She then pursued a combined anatomic and clinical pathology residency and cytopathology fellowship at Duke University. Following several years on faculty at Duke University, she relocated to Charlotte where she has been practicing for 8 years, specializing in Cytopathology and Head and Neck Pathology. She also serves as co-medical directory of the Central Piedmont Community College Cytotechnology program.

Thank you

Description

Contributors

Trisha M Shattuck, MD, PhD.